Abstract
Testicular cancer has been a model for a curable malignancy. The existence of an array of potential new therapies is the result of a prodigious effort in the researching and defining of the molecular components of the cancer phenotype and the subsequent rational design of agents to target candidate pathways. A better understanding of the molecular biology of cancer may also aid in guiding the most appropriate use of existing therapies, such as conventional chemotherapy.
Original language | English |
---|---|
Pages (from-to) | 457-71 |
Number of pages | 15 |
Journal | Hematology/oncology clinics of North America |
Volume | 25 |
Issue number | 3 |
DOIs | |
Publication status | Published - 1 Jun 2011 |